Differential target multiplexed SCS (DTM SCS): a rational hypothesis
Pain Medicine · 01.06.2026 · 27 (Supplement_1) · S17-S34
DOI: 10.1093/pm/pnag041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pain Medicine, online erschienen am 10.06.2026. Verfasst von Leonardo Kapural und 9 weiteren Autor:innen. Beteiligte Einrichtung: Carolinas Pain Institute, Winston-Salem, NC, United States. Hauptthemen laut MEDLINE: Spinal Cord Stimulation, Low Back Pain, Chronic Pain. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic Neuromodulation.
Abstract (Originalsprache)
Background
Early in the development of technology for spinal cord stimulation (SCS) therapy, the challenge of treating chronic low back pain was met with specific electrode configurations and programming parameters designed to target and maintain paresthesia in that region. New modalities were subsequently developed to achieve long-term relief of chronic low back and leg pain and minimize unwanted stimulation. Only recently has it become clear that SCS mechanisms for modulating pain involve not only the activation of Aβ-fibers but also other mechanisms, such as the modulation of biological processes at the glial cells and neuroglial interaction. Content overview Differential Target MultiplexedTM (DTMTM) programming, a combination of multiplexed pulsed signals delivered synchronously at different rates and amplitudes, was shown in animal models to revert neurons and glia in the stimulated spinal cord from an injured state back to a noninjured state in transcriptomics and proteomics studies. This article highlights the rationale for and development of DTM SCS and provides an overview of its clinical application. We review key outcomes of pivotal DTM SCS studies within the context of other randomized clinical trials (RCTs) examining SCS for the treatment of chronic low back pain.
Conclusions
The development of DTM SCS is based on preclinical research, parameter refinement in a feasibility study, and confirmatory RCTs showing promise in enhancing outcomes of patients with chronic low back pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Carolinas Pain Institute, Winston-Salem, NC, United States.
- Lumbrera LLC, Department of Research and Development, Bloomington, IL, United States.
- VA San Diego Healthcare, San Diego, CA, United States.
- Innovative Pain Treatment Solutions and Surgery Centers, San Diego, CA, United States.
- Solaris Research Institute, San Diego, CA, United States.
- Rijnstate Hospital, Department of Anesthesiology and Pain Management, Arnhem, Netherlands.
ORCID-Profile: Leonardo Kapural, Julia E Gamache, Lisa M Johanek
Förderung
- Medtronic Neuromodulation
Zitieren
APA
Kapural, L., Vallejo, R., Cedeño, D. L., Chakravarthy, K., Kallewaard, J. W., Abd-Elsayed, A., Fishman, M. A., Murphy, M., Gamache, J. E., & Johanek, L. M. (2026). Differential target multiplexed SCS (DTM SCS): a rational hypothesis. Pain Medicine, 27(Supplement_1), S17-S34. https://doi.org/10.1093/pm/pnag041
Vancouver
Kapural L, Vallejo R, Cedeño DL, Chakravarthy K, Kallewaard JW, Abd-Elsayed A, et al. Differential target multiplexed SCS (DTM SCS): a rational hypothesis. Pain Medicine. 2026;27(Supplement_1):S17-S34. doi:10.1093/pm/pnag041
BibTeX
@article{Kapural2026,
author = {Kapural, Leonardo and Vallejo, Ricardo and Cedeño, David L and Chakravarthy, Krishnan and Kallewaard, Jan Willem and Abd-Elsayed, Alaa and Fishman, Michael A and Murphy, Melissa and Gamache, Julia E and Johanek, Lisa M},
title = {Differential target multiplexed SCS (DTM SCS): a rational hypothesis},
journal = {Pain Medicine},
year = {2026},
volume = {27},
number = {Supplement_1},
pages = {S17--S34},
doi = {10.1093/pm/pnag041}
}
EUVIMED